Class 4 caution in use-Tramadol 50 mg capsules & PR capsules

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Tramadol 50 mg capsules & PR capsules

Morningside Healthcare Limited has informed the MHRA of a packaging issue identified in batch MRA2303 of Tramadol Hydrochloride Morningside 50 mg Prolonged-Release Capsules and batch MRF2301 of Tramadol Hydrochloride 50 mg Capsules.

MHRA Drug alert date: 27th November 2024

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-morningside-healthcare-limited-tramadol-hydrochloride-50-mg-capsules-and-tramadol-hydrochloride-morningside-50-mg-prolonged-release-capsules-el-24-a-slash-57

Pip code	Product description	Supplier	Batch Numbers
1085463	TRAMADOL CAP 50MG ACC	Morningside Healthcare Limited	MRF2301
1140128	TRAMADOL CAP 50MG ALM	Morningside Healthcare Limited	MRF2301
Alliance do not stock	TRAMADOL PR CAP 50MG (60)	Morningside Healthcare Limited	MRA2303

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries and reports of missing capsules or blister strips, please email medinfo@aspirepharma.co.uk or telephone 01730231148.

For all stock enquiries, please email mplcustomerservices@morningsidepharm.com or telephone 01730231148.